Bone Marrow Toxicity and Tolerance of Sandwich Therapy for Advanced-Stage Endometrial Cancer: A Single-Institution Experience

被引：0
|
作者：
Jalai, C. [1 ,2 ]
Tang, J. [2 ,3 ]
Gabor, L. [1 ,2 ]
Jiang, J. M. [2 ,3 ]
Lin, K. [1 ,2 ]
Kuo, D. [1 ,2 ]
Mehta, K. J. [2 ,3 ]
机构：
[1] Albert Einstein Coll Med, Dept Gynecol Oncol, Bronx, NY 10467 USA
[2] Montefiore Med Ctr, 111 E 210th St, Bronx, NY 10467 USA
[3] Albert Einstein Coll Med, Dept Radiat Oncol, Bronx, NY 10467 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2022年 / 114卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2606
引用
收藏
页码：E271 / E272
页数：2
相关论文
共 50 条
  • [31] Single-institution experience of total neoadjuvant therapy for locally advanced rectal cancer: Long-term results
    Spatola, C.
    Privitera, G.
    Milazzotto, R.
    Liardo, R.
    Salamone, V.
    Raffaele, L.
    Foti, P.
    Basile, A.
    Palmucci, S.
    Licata, A.
    Di Cataldo, A.
    Amico, A.
    Acquaviva, G.
    Li Destri, G.
    ANNALS OF ONCOLOGY, 2020, 31 : S97 - S97
  • [32] The Role of Stereotactic Body Radiation Therapy for Pancreatic Cancer: A Single-Institution Experience
    Moningi, Shalini
    Dholakia, Avani S.
    Raman, Siva P.
    Blackford, Amanda
    Cameron, John L.
    Le, Dung T.
    De Jesus-Acosta, Ana M. C.
    Hacker-Prietz, Amy
    Rosati, Lauren M.
    Assadi, Ryan K.
    Dipasquale, Shirl
    Pawlik, Timothy M.
    Zheng, Lei
    Weiss, Matthew J.
    Laheru, Daniel A.
    Wolfgang, Christopher L.
    Herman, Joseph M.
    ANNALS OF SURGICAL ONCOLOGY, 2015, 22 (07) : 2352 - 2358
  • [33] The Role of Stereotactic Body Radiation Therapy for Pancreatic Cancer: A Single-Institution Experience
    Shalini Moningi
    Avani S. Dholakia
    Siva P. Raman
    Amanda Blackford
    John L. Cameron
    Dung T. Le
    Ana M. C. De Jesus-Acosta
    Amy Hacker-Prietz
    Lauren M. Rosati
    Ryan K. Assadi
    Shirl Dipasquale
    Timothy M. Pawlik
    Lei Zheng
    Matthew J. Weiss
    Daniel A. Laheru
    Christopher L. Wolfgang
    Joseph M. Herman
    Annals of Surgical Oncology, 2015, 22 : 2352 - 2358
  • [34] Chemotherapy and the standard of care: A single-institution review of advanced stage ovarian cancer patients
    Dholakiya, Priyal
    Newtson, Andreea M.
    Zhang, Catherine
    Friesth, Tana
    Krohn, Michelle
    Racek, Adrianne
    Button, Anna
    Mott, Sarah L.
    Goodheart, Michael J.
    GYNECOLOGIC ONCOLOGY, 2015, 139 (01) : 180 - 180
  • [35] The prognostic significance of chemotherapy for stage IV gastric cancer patients: A single-institution experience
    Toshiro Okuyama
    Daisuke Korenaga
    Kenichi Koushi
    Shinji Itoh
    Hirofumi Kawanaka
    Yasuharu Ikeda
    Kenji Takenaka
    Surgery Today, 2011, 41 : 935 - 940
  • [36] Pattern of Use of Adjuvant Chemotherapy for Stage II Colon Cancer: A Single-Institution Experience
    Osarogiagbon, Raymond U.
    Sachdev, Jasgit C.
    Khattak, Amna G.
    Kronish, Lori E.
    CLINICAL COLORECTAL CANCER, 2009, 8 (02) : 94 - 99
  • [37] QUALITY CONTROL IN EARLY STAGE CERVICAL CANCER MANAGEMENT: A SINGLE-INSTITUTION'S EXPERIENCE
    Shim, J. E.
    Kim, M. K.
    Kim, Y. H.
    Kim, S. C.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2021, 31 : A55 - A56
  • [38] INTRAOPERATIVE ELECTRON RADIOTHERAPY IN EARLY STAGE BREAST CANCER. A SINGLE-INSTITUTION EXPERIENCE
    Dall'Oglio, S.
    Maluta, S.
    Marciai, N.
    Gabbani, M.
    Franchini, Z.
    Pietrarota, P.
    Meliado, G.
    Guariglia, S.
    Cavedon, C.
    CANCER RESEARCH, 2012, 72
  • [39] The Prognostic Significance of Chemotherapy for Stage IV Gastric Cancer Patients: A Single-Institution Experience
    Okuyama, Toshiro
    Korenaga, Daisuke
    Koushi, Kenichi
    Itoh, Shinji
    Kawanaka, Hirofumi
    Ikeda, Yasuharu
    Takenaka, Kenji
    SURGERY TODAY, 2011, 41 (07) : 935 - 940
  • [40] Chemotherapy with gemcitabine and oxaliplatin in patients with advanced biliary tract cancer: A single-institution experience
    Manzione, Luigi
    Romano, Rosangela
    Germano, Domenico
    ONCOLOGY, 2007, 73 (5-6) : 311 - 315
12345